Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort

被引:1
|
作者
Ruiz-Irastorza, Guillermo [1 ]
Paredes-Ruiz, Diana [2 ]
Herrero-Galvan, Maria [3 ]
Moreno-Torres, Victor [4 ]
Hernandez-Negrin, Halbert [5 ,6 ]
Ruiz-Arruza, Ioana [1 ]
Leonard, Cedric [7 ]
Richez, Christophe [7 ]
Lazaro, Estibaliz [7 ]
机构
[1] Univ Basque Country, UPV EHU, Biobizkaia Hlth Res Inst, Bizkaia, Spain
[2] Biobizkaia Hlth Res Inst, Bizkaia, Spain
[3] Univ Basque Country, UPV EHU, Bizkaia, Spain
[4] Hosp Univ Cruces, Hosp Univ Puerta Hierro Majadahonda, UNIR Hlth Sci Sch, Madrid, Spain
[5] Hosp Univ Cruces, Hosp Reg Univ Malaga, Malaga, Spain
[6] Univ Malaga, Malaga, Spain
[7] Bordeaux Univ Hosp, Bordeaux, France
关键词
D O I
10.1002/acr.25334
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. The objective of this study was to analyze the effect of methylprednisolone pulses (MP), given during the first year after the diagnosis of systemic lupus erythematosus (SLE), in achieving prolonged remission according to the degree of lupus activity at presentation. Methods. We conducted an observational study of routine clinical care data from the Lupus-Cruces-Bordeaux cohort. The end point was prolonged remission (ie, during five consecutive yearly visits). The effect of MP on remission during the first year was analyzed in the whole cohort and according to the baseline Systemic Lupus Erythematosus Disease Activity Index 2000 score: <6, 6 to 12, and >12, reflecting mild, moderate, and severe activity, respectively. For adjustment, logistic regression with propensity score (PS) and other therapeutic covariates was performed. Results. Two hundred thirty-three patients were included. Prolonged remission was achieved by 132 patients (57%). MP were associated with prolonged remission (PS-adjusted odds ratio [OR] 2.50, 95% confidence interval [CI] 1.04-623, P = 0.042). A strong clinical effect was seen among patients with moderate (adjusted OR 5.28, 95% CI 1.27-21.97, P = 0.022) and moderate-severe SLE activity (adjusted OR 4.07, 95% CI 1.11-14.82, P = 0.033). The administration of MP resulted in reduced average dosages of prednisone during the first year among patient with moderate (mean 6.6 vs 10.2 mg/day, P = 0.017) and severe activity (mean 14 vs 28 mg/day, P = 0.015). The odds of prolonged remission were increased by longer-term use of hydroxychloroquine (HCQ) and decreased by higher initial doses of prednisone. Conclusion. This study supports the use of MP to induce prolonged remission in patients with SLE, particularly in those with moderate and severe activity. The extended use of HCQ also contributes to achieve prolonged remission. image
引用
收藏
页码:1132 / 1138
页数:7
相关论文
共 50 条
  • [31] Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort
    Choi, May Y.
    Clarke, Ann E.
    St Pierre, Yvan
    Hanly, John G.
    Urowitz, Murray B.
    Romero-Diaz, Juanita
    Gordon, Caroline
    Bae, Sang-Cheol
    Bernatsky, Sasha
    Wallace, Daniel J.
    Merrill, Joan T.
    Isenberg, David A.
    Rahman, Anisur
    Ginzler, Ellen M.
    Petri, Michelle
    Bruce, Ian N.
    Dooley, Mary A.
    Fortin, Paul R.
    Gladman, Dafna D.
    Sanchez-Guerrero, Jorge
    Steinsson, Kristjan
    Ramsey-Goldman, Rosalind
    Khamashta, Munther A.
    Aranow, Cynthia
    Alarcon, Graciela S.
    Manzi, Susan
    Nived, Ola
    Zoma, Asad A.
    van Vollenhoven, Ronald F.
    Ramos-Casals, Manuel
    Ruiz-Irastorza, Guillermo
    Lim, S. Sam
    Kalunian, Kenneth C.
    Inanc, Murat
    Kamen, Diane L.
    Peschken, Christine A.
    Jacobsen, Soren
    Askanase, Anca
    Stoll, Thomas
    Buyon, Jill
    Mahler, Michael
    Fritzler, Marvin J.
    ARTHRITIS CARE & RESEARCH, 2019, 71 (07) : 893 - 902
  • [32] NEUROPATHIES IN SYSTEMIC LUPUS ERYTHEMATOSUS: RESULTS FROM AN INTERNATIONAL, INCEPTION COHORT STUDY
    Hanly, John
    Li Qiuju
    Li Su
    Urowitz, Murray B.
    Gordon, Caroline
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Sanchez-Guerrero, Jorge
    Bernatsky, Sasha
    Clarke, Ann E.
    Wallace, Daniel J.
    Isenberg, David
    Rahman, Anisur
    Merrill, Joan T.
    Fortin, Paul
    Gladman, Dafna D.
    Bruce, Ian N.
    Petri, Michelle A.
    MGinzler, Ellen
    Dooley, M. A.
    Steinsson, Kristjan
    Ramsey-Goldman, Rosalind
    Zoma, Asad A.
    Manzi, Susan
    Nived, Ola
    Jonsen, Andreas
    Khamashta, Munther
    Alarcon, Graciela S.
    van Vollenhoven, Ronald F.
    Svenungsson, Elisabet
    Aranow, Cynthia
    Mackay, Meggan
    Ruiz-Irastorza, Guillermo
    Ramos-Casals, Manuel
    Lim, S. Sam
    Inanc, Murat
    Kalunian, Kenneth C.
    Jacobsen, Soren
    Peschken, Christine
    Kamen, Diane L.
    Askanase, Anca
    Theriault, Chris
    Farewell, Vernon
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 206 - 207
  • [33] Major infections in newly diagnosed systemic lupus erythematosus: an inception cohort study
    Wang, Haiting
    Zhou, Yuhong
    Yu, Liqin
    Wu, Wanlong
    Zhao, Liling
    Geng, Shikai
    Sun, Fangfang
    Zhang, Danting
    Shen, Nan
    Chen, Yi
    Ye, Shuang
    LUPUS SCIENCE & MEDICINE, 2022, 9 (01):
  • [34] Electrocardiographic Findings in Systemic Lupus Erythematosus: Data From an International Inception Cohort
    Bourre-Tessier, Josiane
    Urowitz, Murray B.
    Clarke, Ann E.
    Bernatsky, Sasha
    Krantz, Mori J.
    Thao Huynh
    Joseph, Lawrence
    Belisle, Patrick
    Bae, Sang-Cheol
    Hanly, John G.
    Wallace, Daniel J.
    Gordon, Caroline
    Isenberg, David
    Rahman, Anisur
    Gladman, Dafna D.
    Fortin, Paul R.
    Merrill, Joan T.
    Romero-Diaz, Juanita
    Sanchez-Guerrero, Jorge
    Fessler, Barri
    Alarcon, Graciela S.
    Steinsson, Kristjan
    Bruce, Ian N.
    Ginzler, Ellen
    Dooley, Mary Anne
    Nived, Ola
    Sturfelt, Gunnar
    Kalunian, Kenneth
    Ramos-Casals, Manuel
    Petri, Michelle
    Zoma, Asad
    Pineau, Christian A.
    ARTHRITIS CARE & RESEARCH, 2015, 67 (01) : 128 - 135
  • [35] Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort study
    Golder, Vera
    Kandane-Rathnayake, Rangi
    Huq, Molla
    Louthrenoo, Worawit
    Luo, Shue Fen
    Wu, Yeong-jian Jan
    Lateef, Aisha
    Sockalingam, Sargunan
    Navarra, Sandra, V
    Zamora, Leonid
    Hamijoyo, Laniyati
    Katsumata, Yasuhiro
    Harigai, Masayoshi
    Chan, Madelynn
    O'Neill, Sean
    Goldblatt, Fiona
    Lau, Chak Sing
    Li, Zhan Guo
    Hoi, Alberta
    Nikpour, Mandan
    Morand, Eric F.
    LANCET RHEUMATOLOGY, 2019, 1 (02): : E103 - E110
  • [36] External Validation of the Lupus Impact Tracker in a Southeastern US Longitudinal Cohort With Systemic Lupus Erythematosus
    Brandt, Jennifer E.
    Drenkard, Cristina
    Kan, Hong
    Bao, Gaobin
    Dunlop-Thomas, Charmayne
    Pobiner, Bonnie
    Chang, David J.
    Jolly, Meenakshi
    Lim, S. Sam
    ARTHRITIS CARE & RESEARCH, 2017, 69 (06) : 842 - 848
  • [37] Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort
    David, Trixy
    Su, Li
    Cheng, Yafeng
    Gordon, Caroline
    Parker, Benjamin
    Isenberg, David
    Reynolds, John A.
    Bruce, Ian N.
    Int Collaborating Clin Consortium
    MASTERPLANS Consortium
    LUPUS, 2023, 32 (09) : 1043 - 1055
  • [38] Remission and low disease activity (LDA) prevent damage accrual in patients with systemic lupus erythematosus: results from the Systemic Lupus International Collaborating Clinics (SLICC) inception cohort
    Francisco Ugarte-Gil, Manuel
    Hanly, John
    Urowitz, Murray
    Gordon, Caroline
    Bae, Sang-Cheol
    Romero-Diaz, Juanita
    Sanchez-Guerrero, Jorge
    Bernatsky, Sasha
    Clarke, Ann Elaine
    Wallace, Daniel J.
    Isenberg, David Alan
    Rahman, Anisur
    Merrill, Joan T.
    Fortin, Paul R.
    Gladman, Dafna D.
    Bruce, Ian N.
    Petri, Michelle
    Ginzler, Ellen M.
    Dooley, Mary Anne
    Ramsey-Goldman, Rosalind
    Manzi, Susan
    Jonsen, Andreas
    van Vollenhoven, Ronald F.
    Aranow, Cynthia
    Mackay, Meggan
    Ruiz-Irastorza, Guillermo
    Lim, Sam
    Inanc, Murat
    Kalunian, Ken
    Jacobsen, Soren
    Peschken, Christine
    Kamen, Diane L.
    Askanase, Anca
    Pons-Estel, Bernardo A.
    Alarcon, Graciela S.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (11) : 1541 - 1548
  • [39] A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus
    Letchumanan, Pagalavan
    Ng, Heng-Joo
    Lee, Lai-Heng
    Thumboo, Julian
    RHEUMATOLOGY, 2009, 48 (04) : 399 - 403
  • [40] Male systemic lupus erythematosus in a Latin-American inception cohort of 1214 patients
    Garcia, MA
    Marcos, JC
    Marcos, AI
    Pons-Estel, BA
    Wojdyla, D
    Arturi, A
    Babini, JC
    Catoggio, LJ
    Alarcon-Segovia, D
    LUPUS, 2005, 14 (12) : 938 - 946